Novartis scientist visit to Korea for a cancer scientific seminar.

Published: 2005-09-16 06:55:00

Updated: 2005-09-16 06:55:00

Dr. D. Young, the vice president responsible for the Novartis global clinical research on phase II/III studies, visited to Korea for the Asia-Pacific Scientific Seminar on Cancer in Seoul, staying 4 days.

Dr. Young has been responsible for the global clinical phase II/III studies on anti-cance...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK